CS
AGN

Credit Suisse’s Allergan plc AGN Stock Holding History

Credit Suisse’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-10,733,794
Closed -$1.9B – 4286
2020
Q1 		$1.9B Buy
10,733,794
+2,038,130
+23% +$384M 1.64% 5
2019
Q4 		$1.66B Buy
8,695,664
+959,598
+12% +$173M 1.21% 7
2019
Q3 		$1.3B Buy
7,736,066
+6,266,725
+426% +$1.02B 1.1% 9
2019
Q2 		$246M Buy
1,469,341
+751,706
+105% +$104M 0.22% 78
2019
Q1 		$105M Sell
717,635
-27,110
-4% -$3.93M 0.1% 208
2018
Q4 		$99.5M Sell
744,745
-17,134
-2% -$2.81M 0.1% 182
2018
Q3 		$145M Buy
761,879
+44,536
+6% +$8.18M 0.13% 142
2018
Q2 		$120M Sell
717,343
-281,906
-28% -$45.3M 0.12% 151
2018
Q1 		$168M Buy
999,249
+310,774
+45% +$52.1M 0.16% 116
2017
Q4 		$113M Sell
688,475
-87,156
-11% -$15.6M 0.1% 191
2017
Q3 		$159M Buy
775,631
+239,394
+45% +$55.7M 0.15% 120
2017
Q2 		$133M Sell
536,237
-289,546
-35% -$68M 0.13% 142
2017
Q1 		$197M Sell
825,783
-1,001,800
-55% -$233M 0.18% 103
2016
Q4 		$384M Buy
1,827,583
+955,340
+110% +$198M 0.38% 43
2016
Q3 		$201M Buy
872,243
+76,962
+10% +$18.8M 0.19% 93
2016
Q2 		$184M Buy
795,281
+96,597
+14% +$22.3M 0.2% 91
2016
Q1 		$187M Sell
698,684
-466,403
-40% -$134M 0.23% 84
2015
Q4 		$364M Buy
1,165,087
+291,106
+33% +$86.7M 0.42% 34
2015
Q3 		$238M Buy
873,981
+717,930
+460% +$221M 0.28% 64
2015
Q2 		$47.4M Sell
156,051
-795,951
-84% -$237M 0.05% 444
2015
Q1 		$283M Buy
952,002
+271,219
+40% +$77.3M 0.29% 69
2014
Q4 		$175M Sell
680,783
-87,935
-11% -$22M 0.16% 131
2014
Q3 		$185M Buy
768,718
+299,437
+64% +$67M 0.15% 122
2014
Q2 		$105M Buy
469,281
+12,380
+3% +$2.56M 0.09% 217
2014
Q1 		$94.1M Sell
456,901
-54,736
-11% -$10.8M 0.09% 212
2013
Q4 		$86M Buy
+511,637
New +$80M 0.08% 236
2013
Q3 		– Sell
-461,799
Closed -$58.3M – 4429
2013
Q2 		$58.3M Buy
+461,799
New +$52.3M 0.06% 325

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Credit Suisse's AGN Position: Q2 2020 in Review

Credit Suisse sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 10,733,794 shares — an estimated $1.9B sold.

Credit Suisse first reported a position in AGN in Q2 2013 and held it in 27 quarters. The position peaked at $1.9B in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Credit Suisse reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Credit Suisse sold 10,733,794 Allergan plc shares in Q2 2020, an estimated $1.9B.
  • Credit Suisse first reported a position in Allergan plc in Q2 2013 and held it in 27 quarters.
  • Credit Suisse's Allergan plc position peaked at $1.9B in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Credit Suisse's 13F filing for Q2 2020, filed 12 Aug 2020.